GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sincere Co Ltd (TSE:7782) » Definitions » Debt-to-EBITDA

Sincere Co (TSE:7782) Debt-to-EBITDA : 6.33 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Sincere Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sincere Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円1,520 Mil. Sincere Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was 円779 Mil. Sincere Co's annualized EBITDA for the quarter that ended in Dec. 2023 was 円363 Mil. Sincere Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 6.33.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Sincere Co's Debt-to-EBITDA or its related term are showing as below:

TSE:7782' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.6   Med: 2.68   Max: 13.69
Current: 5.05

During the past 10 years, the highest Debt-to-EBITDA Ratio of Sincere Co was 13.69. The lowest was 0.60. And the median was 2.68.

TSE:7782's Debt-to-EBITDA is ranked worse than
86.57% of 432 companies
in the Medical Devices & Instruments industry
Industry Median: 1.21 vs TSE:7782: 5.05

Sincere Co Debt-to-EBITDA Historical Data

The historical data trend for Sincere Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sincere Co Debt-to-EBITDA Chart

Sincere Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.70 1.70 5.47 8.50 4.90

Sincere Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.88 2.79 2.67 4.34 6.33

Competitive Comparison of Sincere Co's Debt-to-EBITDA

For the Medical Instruments & Supplies subindustry, Sincere Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sincere Co's Debt-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sincere Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Sincere Co's Debt-to-EBITDA falls into.



Sincere Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Sincere Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1520.182 + 779.231) / 469.655
=4.90

Sincere Co's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(1520.182 + 779.231) / 363.412
=6.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


Sincere Co  (TSE:7782) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Sincere Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Sincere Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Sincere Co (TSE:7782) Business Description

Traded in Other Exchanges
N/A
Address
30-1, Nihonbashi hakozaki cho, Tama building Nihonbashi Hakozaki, 10th Floor, Chuo-ku, Tokyo, JPN, 103-0015
Sincere Co Ltd is a Japanese firm engaged in the manufacturing and sale of contact lens. It offers daily disposable malleable contact lens, color contact lens, and conventional disposable soft contact lens.

Sincere Co (TSE:7782) Headlines

No Headlines